3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.50
-0.20 (-0.39%)
Apr 24, 2025, 1:46 PM CST
65.33%
Market Cap 4.02B
Revenue (ttm) 265.69M
Net Income (ttm) 91.70M
Shares Out 77.84M
EPS (ttm) 1.30
PE Ratio 39.77
Forward PE n/a
Dividend 0.53 (1.04%)
Ex-Dividend Date n/a
Volume 80,461
Average Volume 604,034
Open 52.00
Previous Close 51.70
Day's Range 51.40 - 52.10
52-Week Range 31.20 - 73.50
Beta 0.38
RSI 41.90
Earnings Date Apr 25, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 33
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.